Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) has announced an upcoming investor webcast scheduled for Thursday, December 19th, 2024, at 2:00 PM ET. The company, a vertically integrated cannabis producer operating two mega facilities in Quebec with over 1,650,000 sq. ft. of space, will feature CFO Nicholas Sosiak presenting key financial and operational results for the fiscal year ended August 31, 2024.
The presentation will be followed by an interactive Q&A session where investors can engage directly with management. Pre-registration is required through the provided Zoom webinar link, and an archived version of the webcast and presentation will be available on Cannara's investor relations website.
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) ha annunciato un prossimo webcast per gli investitori programmato per giovedì 19 dicembre 2024, alle 14:00 ET. L'azienda, un produttore di cannabis verticalmente integrato che gestisce due mega impianti in Quebec con oltre 1.650.000 piedi quadrati di spazio, presenterà il CFO Nicholas Sosiak che illustrerà i risultati finanziari e operativi chiave per l'anno fiscale chiuso il 31 agosto 2024.
La presentazione sarà seguita da una sessione interattiva di domande e risposte in cui gli investitori potranno interagire direttamente con il management. È necessaria la registrazione anticipata attraverso il link fornito per il webinar Zoom, e una versione archiviata del webcast e della presentazione sarà disponibile sul sito delle relazioni con gli investitori di Cannara.
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) ha anunciado un próximo webcast para inversores programado para jueves 19 de diciembre de 2024, a las 2:00 PM ET. La empresa, un productor de cannabis verticalmente integrado que opera dos mega instalaciones en Quebec con más de 1.650.000 pies cuadrados de espacio, contará con la presentación del CFO Nicholas Sosiak, quien presentará los resultados financieros y operativos clave para el año fiscal que terminó el 31 de agosto de 2024.
La presentación será seguida de una sesión de preguntas y respuestas interactiva donde los inversores podrán interactuar directamente con la dirección. Se requiere preinscripción a través del enlace del webinar de Zoom proporcionado, y una versión archivada del webcast y la presentación estará disponible en el sitio web de relaciones con inversores de Cannara.
카나라 바이오텍 (TSXV: LOVE) (OTCQB: LOVFF)는 2024년 12월 19일 목요일, 오후 2시 ET에 예정된 투자자 웹캐스트를 발표했습니다. 이 회사는 퀘벡에 두 개의 대형 시설을 운영하는 수직적으로 통합된 대마초 생산업체로, 1,650,000 평방피트 이상의 공간을 보유하고 있으며, CFO인 니콜라스 소시아크가 2024년 8월 31일로 종료된 회계연도의 주요 재무 및 운영 결과를 발표할 것입니다.
발표 후에는 투자자들이 경영진과 직접 소통할 수 있는 인터랙티브 Q&A 세션이 진행됩니다. 제공된 Zoom 웨비나 링크를 통해 사전 등록이 필요하며, 웹캐스트와 발표의 아카이브 버전은 카나라의 투자자 관계 웹사이트에서 제공될 것입니다.
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) a annoncé un prochain webinaire pour les investisseurs prévu pour jeudi 19 décembre 2024, à 14h00 HE. L'entreprise, un producteur de cannabis intégré verticalement qui exploite deux méga-installations au Québec avec plus de 1 650 000 pieds carrés d'espace, mettra en avant le CFO Nicholas Sosiak qui présentera les résultats financiers et opérationnels clés pour l'année fiscale se terminant le 31 août 2024.
La présentation sera suivie d'une session de questions-réponses interactive où les investisseurs pourront interagir directement avec la direction. Une préinscription est requise via le lien du webinaire Zoom fourni, et une version archive du webinaire et de la présentation sera disponible sur le site Web des relations avec les investisseurs de Cannara.
Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) hat ein bevorstehendes Webcast für Anleger angekündigt, das für Donnerstag, den 19. Dezember 2024, um 14:00 Uhr ET geplant ist. Das Unternehmen, ein vertikal integrierter Produzent von Cannabis, der zwei Mega-Anlagen in Quebec mit über 1.650.000 Quadratfuß Fläche betreibt, wird CFO Nicholas Sosiak präsentieren, der die wichtigsten finanziellen und operativen Ergebnisse für das am 31. August 2024 endende Geschäftsjahr vorstellt.
Der Präsentation folgt eine interaktive Q&A-Session, in der die Anleger direkt mit dem Management in Kontakt treten können. Eine Registrierung im Voraus ist über den bereitgestellten Zoom-Webinar-Link erforderlich, und eine archivierte Version des Webcasts und der Präsentation wird auf der Investor-Relations-Website von Cannara verfügbar sein.
- None.
- None.
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, December 19th, 2024, at 2:00 PM ET.
During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended August 31, 2024. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A session.
Date & Time: December 19, 2024, at 2:00 PM ET
Webcast Link: https://us02web.zoom.us/webinar/register/WN_QVPjGIwzSvKgaiRBHLBfrQ
To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above. An archived version of the webcast and presentation will be available on the Company's website, https://investors.cannara.ca/
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
CONTACT
| Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
When is Cannara Biotech (LOVFF) hosting its investor webcast for FY2024 results?
What will be covered in Cannara Biotech's (LOVFF) December 2024 investor presentation?
How can investors participate in Cannara Biotech's (LOVFF) December 2024 webcast?
What is the total facility space of Cannara Biotech's (LOVFF) Quebec operations?
Where can investors find the archived version of Cannara Biotech's (LOVFF) December 2024 presentation?
